Refine
Year of publication
Document Type
- Preprint (577)
- Article (386)
- Working Paper (6)
- Conference Proceeding (4)
Language
- English (973)
Has Fulltext
- yes (973)
Is part of the Bibliography
- no (973)
Keywords
- Heavy Ion Experiments (18)
- Hadron-Hadron scattering (experiments) (11)
- BESIII (8)
- Heavy-ion collision (6)
- LHC (6)
- Kollisionen schwerer Ionen (5)
- Europäische Union (4)
- Hadron-Hadron Scattering (4)
- Quark-Gluon Plasma (4)
- Verbraucherpreis (4)
- Währungsunion (4)
- heavy ion collisions (4)
- law of one price (4)
- purchasing power parity (4)
- relative price volatility (4)
- ALICE experiment (3)
- Branching fractions (3)
- EMU (3)
- Hadronic decays (3)
- Jets and Jet Substructure (3)
- Quark Gluon Plasma (3)
- spatial data (3)
- Accelerators & Beams (2)
- Atomic, Molecular & Optical (2)
- Beauty production (2)
- Charm physics (2)
- Charmonium (2)
- Cross section (2)
- Deflation (2)
- Deutschland (2)
- ECB Monetary Policy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Guidelines (2)
- Heavy Ions (2)
- Inflation (2)
- Inflation Convergence (2)
- Italien (2)
- Jets (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Portugal (2)
- Psychiatric disorders (2)
- QGP (2)
- Quark-Gluon-Plasma (2)
- Regional Diversity (2)
- Schweiz (2)
- Single electrons (2)
- Spanien (2)
- Trauma (2)
- UrQMD Modell (2)
- Währungskrise (2)
- contagion (2)
- currency crisis (2)
- gallbladder cancer (2)
- gallbladder cancer xenografts (2)
- pp collisions (2)
- quark-gluon-plasma (2)
- real exchange rate (2)
- Österreich (2)
- 17-AAG (1)
- ADHD (1)
- ALICE (1)
- ALICE detector (1)
- Absolute branching fraction (1)
- Accelerators & storage rings (1)
- Acute myeloid leukemia (1)
- Adult (1)
- Angular distribution (1)
- Annihilation (1)
- Anti-kaon–nucleon physics (1)
- Anti-nuclei (1)
- Atmospheric chemistry (1)
- Atmospheric science (1)
- Atomic & molecular beams (1)
- Ausbreitung (1)
- Beam loss (1)
- Bhabha (1)
- Big Five (1)
- Biological (1)
- Bloodstream infection (1)
- Bloodstream infections (1)
- Branching fraction (1)
- CDH13 (1)
- COVID-19 (1)
- Cancer (1)
- Cell membranes (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge-transfer collisions (1)
- Circular accelerators (1)
- Classification (1)
- Climate change (1)
- Clinical genetics (1)
- Closure (1)
- Cluster (1)
- Collective Flow (1)
- Conservative (1)
- Cross section measurements (1)
- D meson (1)
- D0 and D+ mesons (1)
- Dalitz decay (1)
- Distributed software development (1)
- D⁰ meson (1)
- Electromagnetic amplitude (1)
- Electromagnetic form factor (1)
- Electron-pion identification (1)
- Electronic transitions (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Embolization (1)
- Energie (1)
- Equation of state (1)
- Europäische Zentralbank (1)
- Fibre/foam sandwich radiator (1)
- Fistula (1)
- Geldpolitik (1)
- Geometrical modelling (1)
- Geometrisches Modellieren (1)
- Geschichte 1990-1999 (1)
- Gram negative bacteria (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- HSP90 inhibitors (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hadronic cross section (1)
- Hadrons (1)
- Heavy Ion Experiment (1)
- Heavy Quark Production (1)
- Heavy flavor production (1)
- Heavy ion collisions (1)
- Heavy ion storage ring (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Hematology (1)
- Hematopoietic stem cell transplantation (1)
- Human behaviour (1)
- Initial state radiation (1)
- Intensive care units (1)
- Intra-abdominal infection (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- J/ϕ (1)
- Japan (1)
- Kanada (1)
- Kaonic nuclei (1)
- Laparostomy (1)
- Library screening (1)
- Local thermodynamical equilibrium (1)
- Low & intermediate-energy accelerators (1)
- Low energy QCD (1)
- Luciferase (1)
- Mesh (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Molecular neuroscience (1)
- Monte Carlo (1)
- Monte-Carlo model for relativistic heavy ion collisions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multivariate analysis (1)
- Muon anomaly (1)
- NMR spectroscopy (1)
- Neural network (1)
- Neutropenia (1)
- Nichtgleichgewicht (1)
- Non-equilibrium effects (1)
- Non-operative (1)
- Non-trauma (1)
- Nutrition (1)
- Objectoriented technology (1)
- Objektorientierte Technologie (1)
- Oncology (1)
- Open abdomen (1)
- Orbital electron capture (1)
- Pancreatitis (1)
- Partial wave analysis (1)
- Particle Correlations and Fluctuations (1)
- Particle interactions (1)
- Partikel-Wechselwirkungen (1)
- Pediatric (1)
- Peritonitis (1)
- Personalized medicine (1)
- Phase (1)
- Phosphorylation (1)
- Photon counting (1)
- Pion form factor (1)
- Polarization (1)
- Predictive markers (1)
- Preisstabilität (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton–proton (1)
- QGP signals (1)
- QMD Modell (1)
- QMD model (1)
- Quark Production (1)
- R value (1)
- Radiation detectors (1)
- Rapidity Range (1)
- Re-exploration (1)
- Reintervention (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- SARS-CoV-2 (1)
- SPS (1)
- Simulation (1)
- Single particle decay spectroscopy (1)
- Small molecules (1)
- Software engineering (1)
- Softwaretechnik (1)
- Spleen (1)
- Statistical model (1)
- Stenotrophomonas maltophilia (1)
- Strong amplitude (1)
- Surgery (1)
- Synthetic (1)
- Systematic Uncertainty (1)
- TR (1)
- Technique (1)
- Time Projection Chamber (1)
- Timing (1)
- Tracking (1)
- Transition radiation detector (1)
- Trigger (1)
- Triple quarkonia (1)
- Two body weak decay (1)
- URQMD (1)
- USA (1)
- Ultra-relativistic Quantum Molecular Dynamics model (1)
- Ultrarelativistic Quantum Molecular Dynamics (1)
- Ultrarelativistic Quantum Molecular Model (1)
- Ultrarelativistisches Quant Molekulares Modell (1)
- UrQMD model (1)
- Vascular emergencies (1)
- Vector Boson Production (1)
- Vesicles (1)
- W-exchange (1)
- WYE-354 (1)
- Xenon-based gas mixture (1)
- Y (4260) (1)
- Zustandsgleichung (1)
- accessory proteins (1)
- agreeableness (1)
- border effects (1)
- branching fractions (1)
- cardiovascular pharmacology (1)
- cell-free protein synthesis (1)
- charmed baryon (1)
- chemokines (1)
- dE/dx (1)
- decay (1)
- decays (1)
- dileptons (1)
- diphoton (1)
- e+e− annihilation (1)
- ectosomes (1)
- energy (1)
- energy-dispersive x-ray spectroscopy (1)
- epilepsy (1)
- equation of state (1)
- executive functions (1)
- exosomes (1)
- extracellular vesicles (1)
- flow (1)
- geldanamycin (1)
- goods market integration (1)
- guidelines (1)
- hadron hadron Kollision (1)
- hadron hadron collision (1)
- heart failure (1)
- heavy ion experiments (1)
- heavy ions (1)
- hotspot loci (1)
- intrinsically disordered region (1)
- lokales thermodynamisches Gleichgewicht (1)
- luminosity (1)
- mTOR inhibitors (1)
- microdeletions (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- neurodevelopment (1)
- neurodevelopmental (1)
- nonstructural proteins (1)
- panel unit root test (1)
- particle ratios (1)
- ppK − (1)
- quantum electrodynamics test (1)
- quark gluon plasma (1)
- rapamycin (1)
- real exchange rate volatility (1)
- real exchange rates (1)
- relativistic (1)
- relativistische (1)
- remodelling (1)
- reproducibility (1)
- rigor (1)
- schwere Ione (1)
- spectra (1)
- standardization (1)
- stationarity (1)
- storage rings (1)
- strangeness (1)
- strong Coulomb field (1)
- structural proteins (1)
- therapy (1)
- thermalization (1)
- working memory (1)
- x-ray techniques (1)
- Λc⁺ (1)
- Σ hyperon (1)
Institute
- Physik (942)
- Frankfurt Institute for Advanced Studies (FIAS) (795)
- Informatik (759)
- Medizin (15)
- Center for Financial Studies (CFS) (6)
- ELEMENTS (4)
- Georg-Speyer-Haus (3)
- Geowissenschaften / Geographie (3)
- Hochschulrechenzentrum (3)
- Informatik und Mathematik (3)
Background and Objectives: Proteins of the coagulation system contribute to autoimmune inflammation in patients with multiple sclerosis (MS). On blood-brain barrier (BBB) disruption, fibrinogen enters the CNS and is rapidly converted to fibrin, unfolding pleiotropic autoimmune mechanisms. Fibrin accumulation leads to subsequent proteolytic degradation that results in D-dimer generation. The primary objective of this study was to determine intrathecal levels of D-dimer in CSF as a measure of intrathecal coagulation cascade activation and to evaluate its diagnostic utility in patients with MS in contrast to healthy subjects. Key secondary objectives included analysis of CSF D-dimer in differential diagnoses of MS and its relation to routine clinical markers of disease activity.
Methods: Patients admitted for the assessment of suspected MS were prospectively recruited from October 2017 to December 2020. Blood plasma and citrated CSF samples were analyzed using a highly sensitive luminescent oxygen channeling immunoassay. Intrathecal generation of D-dimer was analyzed by adjusting for CSF/serum albumin (Qalb) and CSF/plasma D-dimer quotients (QD-dimer), and corresponding CSF fibrinogen levels were determined. Final diagnoses after full evaluation and clinical data were recorded.
Results: Of 187 patients, 113 patients received a diagnosis of MS or clinically/radiologically isolated syndrome. We found increased intrathecal CSF D-dimer generation levels (QD-dimer/Qalb-index) for patients with relapsing-remitting MS (RRMS; n = 71, median 4.7, interquartile range [IQR] 2.5–8.0) when compared with those for disease controls (n = 22, median 2.6, IQR 2.1–4.8, p = 0.031). Absolute CSF D-dimer values correlated with CSF fibrinogen levels (r = 0.463; p < 0 .001) and CSF leukocytes (r = 0.273; p = 0.003) and were elevated in MS patients with contrast enhancement (CE) compared with MS patients without CE on MRI (n = 48, median 6 ng/mL, and IQR 3–15.25 vs n = 41, median 4 ng/mL, and IQR 2–7; p = 0.026). Exploratory subgroup analyses indicated a correlation of intrathecal inflammatory activity and CSF D-dimer levels.
Discussion: D-dimer in CSF can be reliably determined and correlates with markers of CNS inflammation and CSF fibrinogen levels. Adjusted for BBB dysfunction, CSF D-dimer may allow the identification of intrathecal coagulation cascade activation in patients with MS.
Classification of Evidence: This study provides Class I evidence that CSF D-dimer levels are elevated in patients with RRMS.
The microscopic phasespace approach URQMD is used to investigate the stopping power and particle production in heavy systems at SPS and RHIC energies. We find no gap in the baryon rapidity distribution even at RHIC. For CERN energies URQMD shows a pile up of baryons and a supression of multi-nucleon clusters at midrapidity.
Myocardial infarction (MI) induces a complex inflammatory immune response, followed by the remodelling of the heart muscle and scar formation. The rapid regeneration of the blood vessel network system by the attraction of hematopoietic stem cells is beneficial for heart function. Despite the important role of chemokines in these processes, their use in clinical practice has so far been limited by their limited availability over a long time-span in vivo. Here, a method is presented to increase physiological availability of chemokines at the site of injury over a defined time-span and simultaneously control their release using biodegradable hydrogels. Two different biodegradable hydrogels were implemented, a fast degradable hydrogel (FDH) for delivering Met-CCL5 over 24 hrs and a slow degradable hydrogel (SDH) for a gradual release of protease-resistant CXCL12 (S4V) over 4 weeks. We demonstrate that the time-controlled release using Met-CCL5-FDH and CXCL12 (S4V)-SDH suppressed initial neutrophil infiltration, promoted neovascularization and reduced apoptosis in the infarcted myocardium. Thus, we were able to significantly preserve the cardiac function after MI. This study demonstrates that time-controlled, biopolymer-mediated delivery of chemokines represents a novel and feasible strategy to support the endogenous reparatory mechanisms after MI and may compliment cell-based therapies.